Skn sub grft f/n/hf/g child
CPT 15277 covers applying a skin substitute graft to sensitive areas like the face, neck, hands, feet, or genitals in children. This procedure helps heal wounds, burns, or surgical sites by applying bioengineered or biological skin substitutes.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Always verify whether procedure is performed in facility or non-facility setting before billing
Impact: Setting misclassification results in $114.18 payment difference between non-facility ($329.93) and facility ($215.75) rates
Document total surface area in square centimeters and specify each anatomic subsite (e.g., right cheek, left hand dorsum) separately in operative note
Impact: Detailed anatomic documentation supports medical necessity and prevents downcoding or denials; enables accurate size-based coding if multiple areas treated
Bill separately for donor site harvest if autograft is used in addition to skin substitute, using appropriate 15XXX codes
Impact: Captures additional $200-400 in reimbursement for harvest procedures that are separately reportable and not bundled with 15277
Report the specific brand/type of skin substitute product using HCPCS codes (Q4XXX series) in addition to 15277 to ensure product cost reimbursement
Impact: Product codes add $500-5000+ in reimbursement depending on substitute type; failure to bill separately leaves significant revenue uncaptured
For staged procedures, document each session independently with clear notation of medical necessity for multiple applications
Impact: Prevents denial of subsequent sessions as duplicates; each properly documented session generates full $329.93 payment
Verify pre-authorization requirements for skin substitute products, as many payers require prior approval for high-cost biologics
Impact: Lack of pre-authorization is leading cause of complete claim denial; securing approval upfront protects $800-6000+ in total procedure reimbursement
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.